Asthma Complete Guide: Inhalers, Triggers & Control
Asthma is a long-term condition in which the airways become inflamed and narrowed — causing wheezing, coughing, chest tightness and breathlessness. It cannot be cured, but it can be controlled. This guide covers inhalers, triggers and daily control.
Open this article in the interactive app
Asthma is a long-term condition in which the airways (the tubes carrying air to the lungs) become inflamed and narrowed, causing wheezing (a whistling sound when breathing out), coughing, chest tightness, and breathlessness. Symptoms come and go — many people feel fine between episodes, which is exactly why asthma is underestimated. Asthma cannot be cured, but it can be controlled — most people with well-controlled asthma live fully normal, active lives.
What does it mean?
Asthma is a long-term condition in which the airways become inflamed and narrowed, causing wheezing, coughing, chest tightness and breathlessness. It cannot be cured, but it can be controlled.
Asthma is a long-term condition in which the airways (the tubes carrying air to the lungs) become inflamed and narrowed, causing wheezing (a whistling sound when breathing out), coughing, chest tightness, and breathlessness. Symptoms come and go — many people feel fine between episodes, which is exactly why asthma is underestimated. Asthma cannot be cured, but it can be controlled — most people with well-controlled asthma live fully normal, active lives.
Common causes
Using 3 or more SABA reliever canisters per year is linked to higher risk of severe asthma attacks — and in a study of 365,000 patients, higher SABA use was linked step-by-step to more attacks and higher mortality (SABINA program).
- The biggest change in asthma care: SABA alone is out.
Global guidelines (GINA 2025) no longer recommend using the blue reliever inhaler (SABA) alone at any step — SABA eases symptoms quickly but does not treat the underlying inflammation, leaving patients at risk of serious attacks (GINA 2025 summary, Touch Respiratory; NICE/BTS/SIGN 2024 alignment). - The preferred approach: anti-inflammatory reliever (AIR).
For mild asthma, GINA's preferred Track 1 uses as-needed low-dose ICS-formoterol — one inhaler that gives quick relief and treats inflammation at the same time. In trials this reduced severe attacks by 60% or more compared with SABA alone (GINA evidence summary). - For moderate–severe asthma: MART.
The same ICS-formoterol inhaler used daily plus as-needed (maintenance-and-reliever therapy) is the preferred approach at higher steps (GINA 2024/2025 track guidance). - SABA overuse is a red flag.
The global SABINA program found that using 3 or more SABA canisters per year is linked to higher risk of severe attacks — and in a study of 365,000 patients, higher SABA use was linked step-by-step to more attacks and higher mortality (SABINA Sweden, PubMed; SABINA Canada). If you finish reliever inhalers quickly, your asthma is not controlled — tell your doctor. - Inhaler technique decides everything.
Many treatment failures are technique failures: not shaking, not breathing in correctly, not holding breath, or not using a spacer with a pressurized inhaler. Ask your doctor or pharmacist to watch you use your inhaler at every visit (GINA 2025 monitoring guidance). - Triggers are personal but common ones include:
dust and dust mites, smoke (cigarettes, chulha/wood smoke, traffic fumes), strong smells and perfumes, cold air, pollen (spring season in Pakistan), viral colds/flu, and for some people exercise or strong emotions. - Children are treated differently.
For children 6–11, GINA recommends daily low-dose ICS as the foundation (not MART, which is not recommended at 6–11 years) — dosing and devices differ by age, so children need a pediatric plan (GINA — ginasthma.org).
When to worry
Seek urgent medical care
Reliever inhaler not working, or needed every few hours / not lasting
Prevention & practical tips
- Ask your doctor about an anti-inflammatory reliever. If you are still on "blue inhaler only," guidelines say that is no longer sufficient — discuss switching to an ICS-containing reliever approach.
- Master your inhaler technique. Use a spacer with puffers if advised; breathe in slowly and deeply; hold your breath ~10 seconds; rinse your mouth after steroid inhalers to prevent thrush.
- Use your preventer every day, even when you feel fine. Asthma inflammation is always there, even between attacks. Stopping the preventer because "I feel better" is the most common cause of flare-ups.
- Know your triggers and reduce them. Dust-proof bedding, no smoking indoors, avoid chulha/wood smoke, wear a scarf over nose/mouth in cold or dusty air, treat colds promptly.
- Keep a written asthma action plan. Your doctor should give you a plan with three zones: green (doing well — continue), yellow (getting worse — step up as instructed), red (emergency — seek care now). Ask for one if you don't have it.
- Track your reliever use. Needing the reliever more than twice a week (apart from before exercise) means poor control — report it.
- Get the flu vaccine yearly and keep vaccinations current — respiratory infections are a top trigger of severe attacks.
FAQs
No — but it can be controlled so well that most people live normally. Control, not cure, is the goal.
Needing it daily (or finishing canisters fast) means poor control and higher risk of severe attacks. Guidelines now recommend an anti-inflammatory reliever instead of SABA alone — talk to your doctor.
At the low doses used in inhalers, side effects are small — especially compared with repeated courses of oral steroids for attacks. Rinsing your mouth after use prevents most local effects. Never stop a prescribed inhaler from fear alone; discuss concerns with your doctor.
Some children improve in teenage years, but asthma can return in adulthood. Keep follow-up even during good years.
No — with well-controlled asthma, exercise is encouraged. Warm up, and use your reliever before exercise if your doctor advised it. Swimming and walking are excellent.
No. Asthma is not contagious — it cannot be caught from or given to anyone.
References
GINA evidence summary
The preferred approach: anti-inflammatory reliever (AIR).
- GINA 2025 summary, Touch Respiratory: https://touchrespiratory.com/insight/gina-2025/
- NICE/BTS/SIGN 2024 alignment: https://vohnetwork.com/voh-exclusives/editorials/asthma-management-in-transition-are-global-guidelines-finally-speaking-the-same-language
- GINA evidence summary: https://pmc.ncbi.nlm.nih.gov/articles/PMC8750058/
- GINA 2024/2025 track guidance: https://novagp.ie/blog/asthma-symptoms-gina-guidelines-ireland
- SABINA Sweden, PubMed: https://pubmed.ncbi.nlm.nih.gov/31949111/
- SABINA Canada: https://pmc.ncbi.nlm.nih.gov/articles/PMC9511146/
- GINA 2025 monitoring guidance: https://ipu.ie/ipu-review-article/asthma-update-gina-2025-guidelines/
- GINA — ginasthma.org: https://ginasthma.org/
Only articles marked Reviewed ✓ with a date have passed Dr. Umer's medical review.
How this article was reviewed
- Written by: Dr. Muhammad Umer Farooq, MBBS — October 2026
- Medical review: Completed by Dr. Muhammad Umer Farooq, MBBS — October 2026. All medical content was provided and verified by Dr. Umer.
- Found an error? Tell Dr. Umer by email